Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
42 participants
INTERVENTIONAL
2019-10-03
2020-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Studies have already shown the effectiveness of yoga practice on various arthralgia's, on the reduction of inflammatory reactions, on psychological disorders/sleep disorders and on quality of life. Considering quality of life as a global experience of balance between physical and mental wellbeing, the hypothesis was that the practice of yoga would globally improve the quality of life of patients with chronic chikungunya.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Exercise Program on the Functionality of Individuals With Chikungunya Fever
NCT03702348
Effects of 3 Months of Supervised Exercise Training
NCT01349166
The Acute Impact of Yoga-based Stretching on Inflammation and Its Resolution
NCT04444102
Yoga for the Treatment of Metabolic Syndrome
NCT00605436
The Effect of Yoga Exercises and Callisthenic Exercises on the Quality of Life in Healthy Individuals
NCT06396169
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Studies have already shown the effectiveness of yoga practice on various arthralgia's, on the reduction of inflammatory reactions, on psychological disorders/sleep disorders and on quality of life. Considering quality of life as a global experience of balance between physical and mental wellbeing, the hypothesis was that the practice of yoga, by improving these different aspects, would globally improve the quality of life of patients with chronic chikungunya.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wait-list control
The delayed intervention group was to benefit from the intervention after week 8.
Wait-list group
The wait-list group benefit from a 8-week yoga program after the interventional group
Yoga
Yoga classes once a week for eight weeks
Yoga group
During 8 weeks, the intervention group attended weekly yoga sessions and had to practice poses at home
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wait-list group
The wait-list group benefit from a 8-week yoga program after the interventional group
Yoga group
During 8 weeks, the intervention group attended weekly yoga sessions and had to practice poses at home
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients had to be between 18 and 70 years old, and be
* patients affiliated to the French social insurance.
Exclusion Criteria
* suffering from pre-existing rheumatic diseases before the Chikungunya infection;
* showing acute symptoms of a Chikungunya infection (documented serology);
* being unable to practice yoga poses ; having been recently treated with methotrexate or corticosteroids (less than 3 months ago);
* being under guardianship, trusteeship or legal protection,
* participating in another research study,
* showing severely impaired physical and/or psychological health, which in the opinion of the investigator, may affect the compliance of the study participant.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Guadeloupe
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mouffias' Medical Center in Guadeloupe.
Pointe-à-Pitre, , Guadeloupe
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01632-55
Identifier Type: OTHER
Identifier Source: secondary_id
PAP/RI2/2019_05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.